e-learning
resources
Munich 2014
Wednesday, 10.09.2014
New studies into pulmonary proteases and antiproteases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
ADAM9 is upregulated in human COPD lungs and in human and murine lung in response to cigarette smoke
F. Polverino, M. Laucho Contreras, M. Divo, V. Pinto-Plata, B. Celli, C. A. Owen (Boston, Albuquerque, United States Of America; Parma, Italy)
Source:
International Congress 2014 – New studies into pulmonary proteases and antiproteases
Session:
New studies into pulmonary proteases and antiproteases
Session type:
Oral Presentation
Number:
4856
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Polverino, M. Laucho Contreras, M. Divo, V. Pinto-Plata, B. Celli, C. A. Owen (Boston, Albuquerque, United States Of America; Parma, Italy). ADAM9 is upregulated in human COPD lungs and in human and murine lung in response to cigarette smoke. Eur Respir J 2014; 44: Suppl. 58, 4856
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Definition and history of sarcoidosis
Related content which might interest you:
Acute cigarette smoke induces accelerated emphysema development in bENaC-overexpressed mice
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Expression of CX3CL1 and CX3CR1 in human asthmatic lung in relation to cell survival
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Impact of cigarette smoke on function and expression of immunoproteasomes
Source: International Congress 2014 – Effect of cigarette smoke on cell behaviour: cell biology, signalling and senescence
Year: 2014
Cigarette smoke affects IL-17A, IL-17F and IL-17 receptor expression in the lung tissue of COPD patients: Ex vivo/in vitro studies
Source: International Congress 2014 – Mechanistic studies of the airway epithelium
Year: 2014
Tiotropium effects on airway inflammatory events in the cat as an animal model for acute cigarette smoke-induced lung inflammation
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Smoking alters alpha1-antitrypsin in alveolar macrophages possibly promoting misfolding
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
Imbalance of immune response functional phenotype and alveolar macrophages phenotype in COPD
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Immunoaging augments sensitivity to cigarette smoke-induced COPD
Source: International Congress 2014 – Effect of cigarette smoke on cell behaviour: cell biology, signalling and senescence
Year: 2014
Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Mapping of eosinophil and basophils in COPD lung tissues
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Myofibroblast expression in airways and alveoli is affected by smoking and COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
A novel non-human primate model of cigarette smoke-induced chronic obstructive pulmonary disease
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Role of chronic exposure to cigarette smoke on endoglin/CD105 expression in airway epithelium
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Ceramide-1-phosphate attenuates cigarette smoke induce lung inflammation
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Effects of chronic cigarette smoke exposure on lung inflammation in ovalbumin-sensitized mice
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Implication of interleukin-10 in the development of COPD induced by cigarette smoke exposure in mice
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
The role of chemokine receptors in the aberrant migration of COPD neutrophils
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Soluble FasL and Fas+ lymphocytes in peripheral blood of non-smoking patients with COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Mucociliary function in bronchial epithelium of COPD and non-COPD patients: In vitro assessment of the effects of fluid restriction
Source: International Congress 2014 – Cell biology 2014
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept